Global BioAccess Fund
The Global BioAccess Fund invests in companies developing novel therapeutics and devices to address serious unmet medical needs in oncology, I&I, rare disease, CNS and cardiology. We fund early-stage companies who need capital to support IND submission and clinical trials.
)
)
){kind=logo}
){kind=logo}
){kind=logo}